請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41342完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 江俊斌(Chun-Pin Chiang) | |
| dc.contributor.author | Chung-Lin Yang | en |
| dc.contributor.author | 楊忠霖 | zh_TW |
| dc.date.accessioned | 2021-06-15T00:16:15Z | - |
| dc.date.available | 2009-09-15 | |
| dc.date.copyright | 2009-09-15 | |
| dc.date.issued | 2009 | |
| dc.date.submitted | 2009-06-05 | |
| dc.identifier.citation | Ampil FL, Hardin JC, Peskind SP, Stucker FJ. Perineural invasion in skin cancer of
the head and neck: a review of nine cases. J Oral Maxillofac Surg 1995;53:34-8. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res1987;95:229-49. Baba M, Imai T, Nishimura M. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997;272:14893-8. Banas B, Wornle M, Berger T. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 2002;168:4301-7. Bankfalvi A, Piffko J. Prognostic and predictive factors in oral cancer: the role of the invasive tumor front. J Oral Pathol Med 2000;29:291-8. Barnes L., Eveson J. W., Reichart P., Sidransky D. World Health Organization Classificatoin of Tumours. Pathology & Genetics of Head and Neck Tumours. IARC Press: Lyon 2005. Barrett J. Rollins. Chemokines. Blood 1997;90:909-928. Basile J, Thiers B, Maize J Sr., Lathers DMR. Chemokine receptor expression in non-melanoma skin cancer. J Cutan Pathol 2008;35:623-629. Bataskis JG. Surgical excision margins: a pathologist’s perspective. Adv Anat Pathol 1999;6:140-8. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JFJr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-7. Blot WJ, McLaughlin JK, Devesa SS, Fraumeni JF. Cancer of the oral cavity and pharynx. In: Cancer Epidemiology and Prevention, Schottenfeld D, Fraumeni JFJr., eds., 2nd ed. Oxford University Press: New York, 1996;pp. 666-80. Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 1992;166:375-81. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better prognostic indicator than Broders’ grading in oral squamous cell carcinomas. J Oral Pathol Med 1989;18:432-7. Brown B, Barnes L, Mazariegos J, Taylor F, Johnson J, Wagner RL. Prognostic factors in mobile tongue and floor of mouth carcinoma. Cancer 1989;64:1195-202. Byers RM, O’Brien J, Waxler J. The therapeutic and prognostic implicatoins of nerve invasion in cancer of the lower lip. Int J Radiat Oncol Biol Phys 1978;4:215-7. Carter RL, Bliss JM, Soo KC, O’Brien CJ. Radical neck dissections for squamous carcinoma: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys 1987;13:825-32. Chattopadhyay A. Epidemiologic study of oral cancer in Eastern India. Indian J Dermatol 1989;4:59-65 Chen HH, Yu CH, Wang JT, Liu BY, Wang YP, Sun A, Tsai TC, Chiang CP. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. Oral Oncol 2007;43:122-9. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999;35:173-9. Chiang CP, Huang JS, Wang JT, Liu BY, Kuo YS, Hahn LJ, Kuo MYP. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999;28:72-6. Chiesa F, Mauri S, Tradati N, Calabrese L, Giugliano G, Ansarin M, Andrle J, Zurrida S, Orecchia R, Scully C. Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol 1999;35:590-6. Immunol 2003;57:534-44. David J, Mortari F. Chemokine receptors A brief overview. Clinical and Applied Immunology Reviews 2000;1:105-25 Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998;188:373-86. Ding Y, Shimada Y, Maeda M, Kawabe A, Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H, Imamura M. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003;15;9:3406-12 D. Max Parkin, Freddie Bray, J. Ferlay, Paola Pisani. Global Cancer Statistics, 2002. CA Cancer J Clin 2005;55;74-108. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a national cancer data base report. Head Neck 2002;24:165-80. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 2006;24:1910-6. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984;148:542-7. Greaves DR, Wang W, Dairaghi DJ. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and its highly expressed in human dendritic cells. J Exp Med 1997;186:837-44. Gunn, Kyuwa, Tam, Kakiuchi, Matsuzawa, Williams, Nakano. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 1999;189:451-60. Gupta PC, Murti PR, Bhonsle RB. Epidemiology of cancer by tobacco products and the significance of TSNA. Crit Rev Toxicol. 1996;26:183-98. Gunther K, Leier J, Henning G, Dimmler A, Weissbach R, Hohenberger W, Forster R. Prediction of lymph node metastasis in colorectal carcinoma by expression of chemokine receptor CCR7. Int J Cancer. 2005;116:726-33 Helliwell TR. Molecular markers of metastasis in squamous carcinomas. J Pathol 2001;194:289-93. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Snijders PJF, Meijer CJLM, Viscidi R, Munoz N, International Agency for Research on Cancer (IARC) Multicentric Cervical Cancer Study Group. The viral etiology of oral cancer: evidence from the IARC multi-centric study. J Natl Cancer Inst 2003;47-51 Hieshima K, Imai T, Openakker G, Van Damme J, Kusuda J, Tei H. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. J Biol Chem 1997;272:5846-53. H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001;23:147-59. Jeng JH, Kuo ML, Hahn LJ, Kuo MYP. Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res 1994;73:1043-9. Kearsley JH, Thomas S. Prognostic markers in cancer of the head and neck region. Anticancer Drugs 1993;4:419-29. Kimsey TE, Campbell AS, Albo D, Wang TN. Co-localization of Macrophage Inflammatory Protein-3α (Mip-3α) and Its Receptor, CCR6, Promotes Pancreatic Cancer Cell Invasion. The Cancer J 2004;10:6 Kim JW, Ferris RL, Whiteside TL. Chemokine C Receptor 7 Expression and Protection of Circulating CD8+ Lymphocytes from Apoptosis. Clin Cancer Res 2005;11(21):7901-10. Kirita T, Okabe S, Izumo T, Sugimura M. Risk factors for the postoperative local recurrence of tongue carcinoma. J Oral Maxillofac Surg 1994;52:149-54. Kodama J, Hasengaowa, Kusumoto T, Seki N, Matsuo T, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y. Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer. Annals of Oncol. 2007;18:70-6. Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 1992;21:261-4 Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995;24:450-3. Kuo MYP, Chang HH, Hahn LJ, Wang JT, Chiang CP. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 1995;24:255-60. Kuo MYP, Cheng SJ, Chen HM, Kok SH, Hahn LJ, Chiang CP. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med 1998;27:428-33. Kuo MYP, Lin CY, Hahn LJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 1999;28:165-9. Kuo MYP, Huang JS, Kok SH, Kuo YS, Chiang CP. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 2002;31:16-22. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc 1976;75:497-505. Laramore GE, Scott CB, al Sarraf M, Haselow RE, Ervin TJ, Wheeler R, Jacobs JR,Schuller DE, Gahbauer RA, Schwade JG, Campbell BH. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 1992;23:705-13. La Vecchia C, Talamini R, Bosetti C, Negri E, Franceschi S. RESPONSE: re: cancer of the oral cavity and pharynx in nonsmokers who drink alcohol and in nondrinkers who smoke tobacco. J Natl Cancer Inst. 1999;91:1337-8. Liu Y, Poon RT, Feng X, Yu WC, Luk JM, Fan ST. Reduced Expression of Chemokine Receptors on Peripheral Blood Lymphocytes in Patients with Hepatocellular Carcinoma. Am J Gastroenterol 2004;99(6):1111-21. Liu Y, Poon RT, Hughes J, Feng X, Yu WC, Fan ST. Chemokine receptors support infiltraion of lymphocyte subpopulatoins in human hepatocellular carcinoma. Clin Immunol 2005;114:174-82. Lopes MA, Nikitakis NG, Reynolds MA, Ord RA, Sauk JJr. Biomarkers predictive of lymph node metastasis in oral squamous cell carcinoma. J Oral Maxillofac Surg 2002;60:142-7. Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 1990;160:410-4. Lo WL, Kao SY, Chi LY, Wong YK, Chang RCS. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 2003;61:751-8. Macfarlane GJ, Macfarlane TV, Lowenfels AB. The influence of alcohol consumption on worldwide trends in mortality from upper aerodigestive tract cancers in men. J Epidemiol Community Health 1996;50:636-9. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994;168:494-8. Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, Inoue H, Mori M. Expression of Chemokine Receptor CCR7 Is Associated with Lymph Node Metastasis of Gastric Carcinoma. Cancer Res 2002;62:2937-2941. Martinez-Gimeno C, Rodriguez EM, Vila CN, Varela CL. Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope 1995;105:728-33. McGavran MH, Bauer WC, Ogura JH. The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer 1961;14:55-66. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6. Nakano H, Mori S, Yonekawa H, Nariuchi H, Matsuzawa A, Kakiuchi T. A novel mutant gene involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood 1998;91:2886-95. Negri E, La Vecchia C, Franceschi S, Tavani A. Attributable risk for oral cancer in northern Italy. Cancer Epidemiol Biomarkers Prev 1993;2:189-93. Neville BW, Damm DD, Allen CM, Bouquot JE. Epithelial Pathology. In: Oral and Maxillofacial Pathology, third edition. 2009. Saunders, an imprint of Elsevier Inc. Okada Y, Mataga I, Katagiri M, Ishii K. A analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma: relationship between grade of hitopathological malignancy and lymph nodes metastasis. Int J Oral Maxillofac Surg 2003;32:284-8. Ou DL, Chen CL, Lin SB, Hsu CH, Lin LI. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol 2006;210:363-73. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferation of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-8. Pitkin L, Luangdilok S, Corbishley C, Wilson POG, Dalton P, Bray D, Mady S, Williamson P, Odutoye T, Evans PR, Syrigos KN, Nutting CM, Barbachano Y, Eccles S, Harrington KJ. Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival. British J of Cancer 2007;97:670-7. Platz H, Fries R, Hudec M. Retrospective DOSAK Study on carcinomas of the oral cavity: results and consequence. J Maxillofac Surg 1985;13:147-53. Rahima B, Shingaki S, Nagata M, Satio C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:423-31. Ravasz LA, Hordijk GJ, Slootweg PJ, Smit F, Van der Tweel I. Uni- and multivariate analysis of eight indications for post-operative radiotherapy and their significance for local-regional cure in advanced head and neck cancer. J Laryngol Otol 1993;107:437-40. Richard JM, Sancho-Garnier H, Micheau C, Saravane D, Cachin Y. Prognostic factors in cervical node metastasis in upper respiratory and digestive tract carcinomas: study of 1713 cases during a 15 year period. Laryngoscope 1987;97:97-101. Roland NJ, Caslin AW, Nash J, Stell PM. Value of grading squamous cell carcinoma of the head and neck. Head Neck 1992;14:224-9. Rubie C, Frick VO, Wagner M, Rau B, Weber C, Kruse B, Kempf K, Tilton B, Konig J, Schilling M. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J Immunol 2006;63:468-77. Rubie C, Frick VO, Wahner M, Weber C, Kruse B, Kempf K, Konig J, Rau B, Schilling M. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J of Gastroenterol 2006;12(:6627-33. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998;28:2760-9. Sallisto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-12. Sanchez-Sanchez N, Riol-Blanco L, de la Rosa G. Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 2004;104:619-25. Sancho M, Vieira JM, Casalou C. Expression and function of the chemokine receptor CCR7 in thyroid carcinomas. J Endocrinol 2006;191(1):229-38 Schimanski CC, Bahre R, Gockel I, Junginger T, Simiantonaki N, Biesterfeld S, Achenbach T, Wehler T, Galle PR, Moehler M. Chemokine receptor CCR7 enhances intrahepatic and lymphatic dissemination of human hepatocellular carcer. Oncol reports 2006;16:109-13. Schliephake H. Prognostic relevance of molecular markers of oral cancer – a review. Int J Oral Maxillofac Surg 2003;32:233-45. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14:409-26. Scully C. Oral squamous cell carcinoma; from an hypothesis about a virus, to concernabout possible sexual transmission. Oral Oncol 2002;38:227-34 Shimizu Y, Murata H, Kashii Y. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be invloved in the amplification of local necroinflammatory response in the liver. Hepatology 2001;34:311-9. Shingaki S, Suzuki I, Nakajima T, Kawasaki T. Evaluation of histopathologic parameters in predicting cervical lymph node metastasis of oral and oropharyngeal carcinomas. Oral Surg Oral Med Oral Pathol 1988;66:683-8. Shingaki S, Takada M, Suzuki I, et al. Impact of clinicopathologic parameters on survival of patients with tongue carcinoma. Asian J Oral Maxillofac Surg 1997;9:107-16. Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 2003;185:278-84. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implicatoins of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003;32:30-4. Taiwan cancer registry. Incidence and death rate annual report, R.O.C. 2006. Taiwan area main causes of death 2007, Department of health, Executive Yuan, R.O.C. Taiwan, 2004. Takanami. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 2003;105:186-89. Thomas S, Kearsley J. Betal quid and oral cancer: a review. Eur J Cancer B Oral Oncol 1993;29B:251-5. Thomas SJ, MacLennan R. Slaked lime and betel nut cancer in Papua New Guinea. Lancet 1992;340:577-8. Tsai TC, Yu CH, Cheng SJ, Liu BY, Chen HM, Chiang CP. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Oral Oncol 2008; In Press. Tsuzuki H, Takahashi N, Kojima A, Narita N, Sunaga H, Takabayashi T, Fujieda S. Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses. Auris Nasus Larynx. 2006;33:37-42. Uchida H, Iwashita Y, Sasaki A, Shibata K, Matsumoto T, Ohta M, Kitano S. Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma. J of Gastroenterol and Hepatol 2006;21:161-8. Umeda M, Yokoo S, Take Y, Omori A, Nakanishi K, Shimada K. Lymph node metastasis in squamous cell carcinoma of the oral cavity: correlation between histologic features and the prevalence of metastasis. Head Neck 1992;14:263-72. Wagner PL, Moo TA, Arora N. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol. 2008 Oct;15(10): 2833-41 Wang J, Xi L, Hunt JL, Gooding W, Whiteside TL, Chen Z. Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 2004;64:1861-6. Warnakulasuriya S, Trivedy C, Peters TJ. Areca nut use: an independent risk factor for oral cancer. Br Med J 2002;324:799-800. Wikipedia. Chemokine. http:// en.wikipedia.org/wiki/Chemokine Woolgar JA. T2 carcinoma of the tongue: the histopathologist’s perspective. Br J Oral Maxillofac Surg 1999;37:187-93. Yamamoto E, Miyakawa A, Kohama G. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral caviity. Head Neck Surg 1984;6:938-47. Yamauchi K, Akbar SM, Horiike N, Michitaka K, Onji M. Increased serum levels of macrophage inflammatory protein-3alpha in hepatocellular carcinoma: relationship with clinical factors and rognostic importance during therapy. Int J Mol Med 2003;11:601-5. Yanagawa Y, Onoe K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities. Blood 2003;101:4923-9. Yan C, Zhu ZG, Yu YY. Expression of vascular endothelial growth factor C and chemokine receptor CCR7 in gastric carcinoma and their values in predicting lymph node metastasis. World J Gastroenterol. 2004;15;10:783-90 Yuen APW, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, Yuen WF, Wei WI. Prognostic factors of clinically stage I and II oral tongue carcinoma – a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002;24:513-20. Yu CH, Chen HH, Wang JT, Liu BY, Wang YP, Sun A, Kuo RC, Chiang CP. Nuclear expression of metastasis-associated protein 1 (MTA1) is inversely related to progression of oral squamous cell carcinoma in Taiwan. J Dent Sci 2007;2:1-10. Zaballos A, Varona R, Gutierrez J, Lind P, Marquez G. Molecular cloning and RNA expression of two new human chemokine receptor-like genes. Biochem. Biophys. Res. Commun. 1996;227:846–53. Zain RB, Gupta PC, Warnakulasuriya S, Shrestha P, Ikeda N, Axell T. Oral lesions associated with betel quid and tobacco chewing habits. Oral Dis 1997;3:204-5 Zhang L, Yang C, Li M. Expression of Chemokine Receptor CXCR4 and CCR7 in laryngeal carcinoma. Lin Chung Er Bi Yan Hou Ke Za Zhi. 2005;19:985-7, 991. Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR. The national cancer data base report on squamous cell carcinoma of the base of tongue. Head Neck 2004;26:660-74. Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, Boffetta P. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, haryngeal and esophageal cancers in Indian men. Int J Cancer 2003;105:681-6. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41342 | - |
| dc.description.abstract | 背景： 化學趨化因子接受器6及7 (CCR6及CCR7) 在人類不同的癌症中被發現有過度表現的現象 , 而且和腫瘤的大小、淋巴結的轉移、臨床的分期、腫瘤的侵犯 , 或病人的預後等有統計上有意義的相關。
方法：本研究利用免疫組織化學染色的方法 , 探討CCR6及CCR7於123例口腔鱗狀細胞癌 (OSCC)、105例口腔上皮變異 (OED; 35例輕度、37例中度、33例重度) , 和25例正常口腔黏膜 (NOM) 之表現。我們計算在口腔鱗狀細胞癌、口腔上皮變異與正常口腔黏膜中的細胞質與細胞膜CCR6或CCR7標記指數 (labeling indices , LIs) , 並比較各組間的差異。我們同時利用統計方法來分析細胞質與細胞膜CCR6或CCR7標記指數與口腔鱗狀細胞癌病人的臨床病理參數與存活率的相關性。 結果：在較高的CCR6 平均標記指數與男性病患 (P=0.042) 或淋巴結轉移 (P=0.027) 之間有著統計上顯著的差異。細胞質與細胞膜CCR7平均標記指數 , 從NOM至OED至OSCC有隨著惡性程度的增加而呈現統計學上有意義增加的情形(P=0.000) , 而且在較大腫瘤 (T3及T4)、淋巴結轉移 (N1、N2及N3) 及轉移淋巴結之淋巴結外散佈、較高的臨床分期 (臨床分期4 )之病患具有較高的表現量。 結論： CCR7在細胞質及細胞膜的表現從NOM至OED至OSCC有顯著的增加 , 而且和Ｔ分期、Ｎ分期及轉移淋巴結之淋巴結外散佈、及臨床分期有相關性。 我們的結果顯示CCR7的表現可以預測台灣OSCC的進展。 | zh_TW |
| dc.description.abstract | Background: Overexpression of chemokine receptors 6 and 7 (CCR6 and CCR7) have been demonstrated in a variety of human cancers and found to be significantly associated with the tumor size, lymph node metastasis, clinical stage, tumor invasion, or prognosis of these cancers.
Methods: In this study, we examined the expression of CCR6 and CCR7 proteins in 123 specimens of oral squamous cell carcinoma (OSCC), 105 specimens of oral epithelial dysplasia (OED; 35 mild, 37 moderate, and 33 severe cases), and 25 specimens of normal oral mucosa (NOM) by immunohistochemistry. The cytoplasmic and membranous CCR6 or CCR7 labeling indices (LIs) in OSCC, OED, and NOM samples were calculated and compared between groups. The correlation between the cytoplasmic and membranous CCR6 or CCR7 LIs in OSCCs and clinicopathological parameters or survival of OSCC patients was analyzed statistically. Results: There was a significant correlation between the higher mean CCR6 LI and OSCCs in male patients (P = 0.042) or with lymph node metastasis (P = 0.027). The mean CCR7 LIs increased significantly from NOM through OED to OSCC samples (P = 0.000). There is a significant correlation between the higher mean CCR7 LI and OSCCs with larger tumor size (P = 0.001), regional lymph node metastasis (P = 0.041), more advanced clinical stage (P = 0.017), and extranodal spread (P = 0.007). Conclusion: The expression of CCR7 significantly increases form NOM through OED to OSCC samples, and is related to T status, N status, clinical staging, and extranodal spread of OSCCs. The CCR7 LI in OSCC samples can predict the progression of OSCC in Taiwan. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T00:16:15Z (GMT). No. of bitstreams: 1 ntu-98-R96422001-1.pdf: 935200 bytes, checksum: 9b688f55743d09baa9ab5a551335d63c (MD5) Previous issue date: 2009 | en |
| dc.description.tableofcontents | 中文摘要…………………………………………………………………7
Abstract………………………………………………………………8 Introduction……………………………………………………………9 Purposes of this study………………………………………………11 Literature Review……………………………………………………12 Part 1: Introduction of oral squamous cell carcinoma……………………12 (i)Epidemiology in the world………………………………………12 (ii)Epidemiology in Taiwan………………………………………13 (iii)Etiology…………………………………………………………13 (iv)Clinical features………………………………………………16 (v)Histologic features………………………………………………18 (vi)Staging and grading……………………………………………19 Part 2: Prognostic factors of oral squamous cell carcinoma……………20 (i)Clinical factors…………………………………………………20 (ii)Histopathological factors……………………………………21 (iii)Molecular factors………………………………………………26 Part 3: Chemokine and Chemokine receptor……………………28 (i)Introduction……………………………………………………28 (ii)Function……………………………………………………………28 (iii)Structural characteristics…………………………………29 (iv)Type…………………………………………………………………30 Part 4: CC chemokine receptor 6…………………………………30 (i)Structure of protein and gene location……………………....30 (ii)Function of CCR6…………………………………………………31 (iii)Regulation of CCR6 expression……………………………...31 (iv)CCR6 expression in normal cells ……………………………32 (v)CCR6 expression in tumor cell lines…………………………33 (vi)CCR6 expression in cancers……………………………………34 (vii)CCR6 expression in OSCC……………………………………36 Part 5: CC chemokine receptor 7………………………………….36 (i)Structure of protein and gene location……………………36 (ii)Function of CCR7…………………………………………………37 (iii)Regulation of CCR7 expression……………………………38 (iv)CCR7 expression in normal cells ……………………………39 (v)CCR7 expression in tumor cell lines…………………………40 (vi)CCR7 expression in cancers……………………………………40 (vii)CCR7 expression in OSCC………………………………………43 Materials and Methods………………………………………………44 Part 1: Patients and specimens………………………………………………44 Part 2: Immunohistochemical staining for CCR6 and CCR7………………………45 Part 3: Statistical analysis……………………………………47 Results…………………………………………………………………48 Part 1: The mean CCR6 or CCR7 LIs for NOM, OED, and OSCC samples…………………………………………………………………48 Part 2: Correlation between the mean CCR6 or CCR7 LIs in OSCCs and clinicopathological parameters of OSCC patients…………………………49 Part 3: Correlation between the mean CCR6 or CCR7 LIs in OSCCs and oral habits of OSCC patients………………………50 Part 4: Correlation between CCR6 or CCR7 LIs in OSCCs and survival of OSCC Patients…………………………………50 Discussion………………………………………………………………51 Conclusion………………………………………………………………56 Reference………………………………………………………………57 | |
| dc.language.iso | en | |
| dc.subject | 口腔癌前病變 | zh_TW |
| dc.subject | 化學趨化因子接受器七 | zh_TW |
| dc.subject | 口腔癌 | zh_TW |
| dc.subject | 化學趨化因子接受器六 | zh_TW |
| dc.subject | oral cancer | en |
| dc.subject | oral precancer | en |
| dc.subject | chemokine receptor 7 | en |
| dc.subject | chemokine receptor 6 | en |
| dc.title | 化學趨化因子接受器六及化學趨化因子接受器七於口腔上皮變異及鱗狀細胞癌之表現 | zh_TW |
| dc.title | Expression of chemokine receptor 6 and chemokine receptor 7 in oral epithelial dysplasia and squamous cell carcinoma | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 97-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 關學婉,張龍昌 | |
| dc.subject.keyword | 化學趨化因子接受器六,化學趨化因子接受器七,口腔癌,口腔癌前病變, | zh_TW |
| dc.subject.keyword | chemokine receptor 6,chemokine receptor 7,oral cancer,oral precancer, | en |
| dc.relation.page | 82 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2009-06-05 | |
| dc.contributor.author-college | 牙醫專業學院 | zh_TW |
| dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
| 顯示於系所單位： | 臨床牙醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-98-1.pdf 未授權公開取用 | 913.28 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。